Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Regeneron Pharmaceuticals
Pharma
Eylea HD sales jump in Q3 but Regeneron still cedes market share
While sales of Regeneron's high-dose version of Eylea were up 29% sequentially, this didn't translate to a bump in Eylea franchise sales in the U.S.
Kevin Dunleavy
Oct 31, 2024 11:37am
Amgen gears up to launch Eylea biosim as Regeneron plots appeal
Oct 23, 2024 10:16am
Clearside's CLS-AX excels in phase 2b trial, set for phase 3
Oct 9, 2024 11:47am
Dupixent takes pharma DTC top spot in September
Oct 7, 2024 10:00am
FDA signs off on Regeneron and Sanofi's Dupixent for COPD
Sep 27, 2024 9:40am
ESMO, WCLC lung cancer data spark hope—and debate
Sep 27, 2024 8:58am